Terms ending in 2032
Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,708,299 | Hedgehog Antagonists Having Zinc Binding Moieties In force · High confidence | Curis, Inc. and Genentech, Inc. | In force | High confidence | |
| US 10,214,514 | Hedgehog Antagonists Having Zinc Binding Moieties In force · High confidence | Curis, Inc. | In force | High confidence | |
| US 10,188,735 | Compositions and Methods for Stabilizing Protein-Containing Formulations In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,938,189 | Compositions and Methods for Stabilizing Protein-Containing Formulations In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 9,487,809 | Decreasing Lactate Level and Increasing Polypeptide Production by Downregulating the Expression of Lactate Dehydrogenase and Pyruvate Dehydrogenase Kinase In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 8,828,990 | N-7 Substituted Purine and Pyrazolopyrimine Compounds, Compositions and Methods of Use In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 10,689,447 | Fc VARIANTS AND METHODS FOR THEIR PRODUCTION In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,547,701 | Novel Compounds and Compositions for the Inhibition of Nampt In force · Medium confidence | Valo Health, Inc. | In force | Medium confidence | |
| US 9,133,187 | Serine/Threonine Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,221,900 | Methods for Identifying Safe and Functional Humanized Antibodies In force · High confidence | Genentech, Inc. | In force | High confidence | |
| 38 more term ends in 2032 · Pro | |||||
10 of 48 patents shown. Soonest term end first, then patent number.
Pro members see all 48.
38 of these are in force and held by Genentech, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.